GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Project 1: Investigation of immune and stromal factors that promote prostate adenocarcinoma progression and castration response

$493,245
Charles L Sawyers · Columbia University Health Sciences · P01 · FY2023 · CA

Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC

$493,176
Jin Chen · Vanderbilt University Medical Center · R01 · FY2021 · CA

Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC

$493,176
Jin Chen · Vanderbilt University Medical Center · R01 · FY2020 · CA

The Core of the Computational Biology

$493,062
Stephen Tc Wong · Methodist Hospital Research Institute · U54 · FY2013 · CA

Tumor-promoting liver injuries and mechanisms

$493,042
Gen-Sheng Feng · University Of California, San Diego · R01 · FY2022 · CA

Tumor-promoting liver injuries and mechanisms

$493,042
Gen-Sheng Feng · University Of California, San Diego · R01 · FY2023 · CA

The connection of innate and adaptive anti-cancer immunity

$493,006
John Greiner · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas

$492,969
Duane A. Mitchell · University Of Florida · R01 · FY2016 · CA

Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str

$492,966
Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2013 · CA

Mechanisms of Epigenetic Plasticity in PDAC

$492,890
Chunling Yi · Georgetown University · R01 · FY2025 · CA

Hepatic steatosis promotes liver metastasis

$492,873
Steven L Teitelbaum · Washington University · R01 · FY2024 · CA

3-Dimensional Retinal Organoid Platform for the Study of Retinoblastoma

$492,819
Daniel Pelaez · University Of Miami School Of Medicine · R01 · FY2021 · CA

Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors

$492,813
Elizabeth Marjorie Cespedes Feliciano · Kaiser Foundation Research Institute · R01 · FY2025 · CA

Cellular Senescence and Control of Gene Expression

$492,785
Judith Campisi · University Of Calif-Lawrenc Berkeley Lab · R37 · FY2007 · AG

Conserved Biology of Tumor and Microenvironment in Breast Cancer Progression

$492,602
Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2010 · CA

Exploring the potential of TET inhibition in cancer immunotherapy

$492,576
Anjana Rao · La Jolla Institute For Immunology · R01 · FY2023 · CA

Exploring the potential of TET inhibition in cancer immunotherapy

$492,576
Anjana Rao · La Jolla Institute For Immunology · R01 · FY2022 · CA

Targeting Hypoxia-Induced Cancer-Cell Adaptation by Direct Inhibition of Akt and

$492,539
Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2009 · CA

Image-guided radiation-induced permeability (IGRIP) for IGDD

$492,442
Stephen J. Kron · University Of Chicago · R01 · FY2017 · CA

A novel preclinical model of spontaneous metastasis

$492,427
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Controlling cancer with aspirin-triggered stimulation of resolution

$492,372
Dipak Panigrahy · Beth Israel Deaconess Medical Center · R01 · FY2013 · CA

Establishment and regulation of the immune suppressive microenvironment in pancreatic cancer

$492,287
Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2022 · CA

Role of breast cancer-secreted miRNA in directing a stromal metabolic plasticity

$492,142
Shizhen Emily Wang · University Of California, San Diego · R01 · FY2018 · CA

EZH2 in cancer biology and novel inhibitors

$492,047
Jun Qi · Dana-Farber Cancer Inst · R01 · FY2019 · CA

Project 1: Strategies to enhance MEK inhibitor efficacy in MUTNRAS melanoma

$492,026
Roger S Lo · University Of California Los Angeles · P01 · FY2024 · CA